Anticoagulant Sodium Citrate Solution
FDA Label NDC 76297-006

Full FDA labeling including Indications, Dosage, Usage, and Precautions

Structured Product Label

The following Structured Product Label (SPL) was submitted to the FDA by Laboratorios Grifols Sa for the product Anticoagulant Sodium Citrate (NDC 76297-006). This document serves as the official prescribing information, containing essential scientific data and clinical materials required for healthcare providers and patients.

This specific version of the label includes detailed information regarding anticoagulant sodium citrate 4% w/v solution usp, caution, other, recommended storage:, package label.principal display panel, and other regulatory disclosures. Use the navigation below to review specific sections of the FDA submission.

Anticoagulant Sodium Citrate 4% W/V Solution Usp

Rx only 250 mL

Intended for use only with  automated apheresis devices.

Each 100 mL contains:
Sodium Citrate (Dihydrate), USP 4.0 g
(pH adjusted with Citric Acid, Monohydrate, USP)

Caution

Not for direct intravenous infusion. The pouch is a moisture barrier. Do not use unless solution is clear and no leaks detected. Single use container. Discard unused portion.

Other

STERILE, nonpyrogenic fluid path.

Laboratorios Grifols, S. A.
SPAIN
Revision: 10/2019

Store at 20°C to 25°C (68°F to 77°F); excursions permitted between 15°C to 30°C (59°F to 86°F) [See USP Controlled Room Temperature]. Brief exposure up to 40°C (104°F) does not adversely affect the product. Protect from freezing.

Package Label.Principal Display Panel

NDC 76297-006-01

Anticoagulant Sodium Citrate 4% w/v
Solution, USP       250 mL


Rx Only

Intended for use only with automated apheresis devices.

Not for direct intravenous infusion.

RECOMMENDED STORAGE: Store at 20° to 25°C (68° to 77°F); excursions permitted between 15° to 30°C (59° to 86°F) [See USP Controlled Room Temperature].
Brief exposure up to 40°C (104°F) does not adversely affect the product.
Protect from freezing.
  

LOT              EXP              1001344

28 x 250 mL

Num.:

GRIFOLS
Laboratorios Grifols, S. A. SPAIN

LOT

EXP

NDC 76297-006-02

Anticoagulant Sodium Citrate 4% w/v
Solution, USP       250 mL


Rx Only

Intended for use only with automated apheresis devices

Each 100 mL contains:
     Sodium Citrate (Dihydrate), USP   4.0 g
     (ph adjusted with Citric Acid, Monohydrate, USP)

Caution: Not for direct intravenous infusion. The pouch is a moisture barrier.
Do not use unless solution is clear and no leaks detected. Single use container.
Discard unused portion.

STERILE, nonpyrogenic fluid path.

RECOMMENDED STORAGE: Store at 20° to 25°C (68° to 77°F); excursions permitted between 15° to 30°C (59° to 86°F) [See USP Controlled Room Temperature]. Brief exposure up to 40°C (104°F) does not adversely affect the product. Protect from freezing. 

Laboratorios Grifols, S. A. SPAIN

GRIFOLS

Carton (Container 76297 006 02)

Carton (Container 76297 006 02)

* Please review the disclaimer below.